13 research outputs found
ΠΡΠ΅ΠΊΡΠΎΡ Π½Π° Π²Π°Π»ΠΏΡΠΎΠ°Ρ Π½Π° ΠΊΠΎΡΡΠΈΠΊΠ°Π»Π½Π°ΡΠ° Π΅Π»Π΅ΠΊΡΡΠΎΠ³Π΅Π½Π΅Π·Π°
ΠΠ° ΠΏΠΎΠΊΠ°ΠΆΠ΅ΠΌΠ΅ Π½Π΅ΠΊΠΎΠΈ Π½Π°ΡΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠΊΠΈ ΠΈΡΠΊΡΡΡΠ²Π° Π·Π° Π΅ΡΠ΅ΠΊΡΠΎΡ Π½Π° Ρ
ΡΠΎΠ½ΠΈΡΠ½ΠΈΠΎΡ ΡΡΠ΅ΡΠΌΠ°Π½ ΡΠΎ Π²Π°Π»ΠΏΡΠΎΡ Π½Π° ΠΊΠΎΡΡΠΈΠΊΠ°Π»Π½Π°ΡΠ° Π΅Π»Π΅ΠΊΡΡΠΎΠ³Π΅Π½Π΅Π·Π°, ΠΊΠΎΠ΅ Π΄ΠΎΡΠ΅Π³Π° ΠΌΠ½ΠΎΠ³Ρ ΠΌΠ°Π»ΠΊΡ Π΅ ΡΡΡΠ΄ΠΈΡΠ°Π½ΠΎ ΠΈΠ°ΠΊΠΎ Π»Π΅ΠΊΠΎΡ Π΅ Π²ΠΎ ΡΠΏΠΎΡΡΠ΅Π±Π° ΠΎΠ΄ 1964 Π³ΠΎΠ΄ΠΈΠ½Π°
Transcatheter Closure of Patent Foramen Ovale: A Single Center Experience
BACKGROUND: Percutaneous transcatheter closure (PTC) of patent foramen ovale (PFO) is implicated in cryptogenic stroke, transitional ischemic attack (TIA) and treatment of a migraine.AIM: Our goal was to present our experience in the interventional treatment of PFO, as well as to evaluate the short and mid-term results in patients with closed PFO.MATERIAL AND METHODS: Transcatheter closure of PFO was performed in 52 patients (67.3% women, mean age 40.7 ΓΒ± 11.7 years). Patients were interviewed for subjective grading of the intensity of headaches before and after the PFO closure.RESULTS: During 2 years of follow-up, there was no incidence of new stroke, TIA and/or syncope. Follow-up TCD performed in 35 patients showed complete PFO closure in 20 patients (57.1%). Out of 35 patients, 22 (62.9%) reported having a migraine before the procedure with an intensity of headaches at 8.1 ΓΒ± 1.9 on a scale from 1 to 10. During 2 years of follow-up, symptoms of a migraine disappeared in 4 (18.2%) and the remaining 18 patients reported the significant decrease in intensity 4.8 ΓΒ± 2.04 (p = 0.0001). In addition, following PFO closure the incidence of the headaches decreased significantly (p = 0.0001).CONCLUSIONS: Percutaneous transcatheter closure of PFO is a safe and effective procedure showing mid-term relief of neurological symptoms in patients as well as significant reduction of migraine symptoms
Evoked potentials in evaluation of solcoseryl (actihamly) effects in the treatment of cerebral atrophic processies
Twenty-five patients with cerebral atrophic processes, either local or diffuse, of various etiology proved by computerized tomography were investigated and treated
ΠΠ΅Π²ΡΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΡΠΊΠΈ ΡΡΡΠ΄ΠΈΠΈ Π²ΠΎ ΠΈΡΠΏΠΈΡΡΠ²Π°ΡΠ΅ΡΠΎ Π½Π° ΡΠ°ΡΠΌΠ°ΠΊΠΎΠΊΠΈΠ½Π΅ΡΠΈΠΊΠ°ΡΠ° Π½Π° Π°Π½ΡΠΈΠ΅ΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ΅
Π¦Π΅Π»: ΠΠ° ΡΠ΅ ΠΏΠΎΠΊΠ°ΠΆΠ΅ Π΄Π΅ΠΊΠ° ΡΠ΅ΡΠ΅Π±ΡΠ°Π»Π½ΠΈΡΠ΅ Π΅Π²ΠΎΡΠΈΡΠ°Π½ΠΈ ΠΏΠΎΡΠ΅Π½ΡΠΈΡΠ°Π»ΠΈ ΡΠ΅ ΠΊΠ°ΠΊΠΎ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π΅Π½ ΠΈΠ½Π΄ΠΈΠΊΠ°ΡΠΎΡ Π²ΠΎ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠΊΠΈΠ½Π΅ΡΠΈΠΊΠ°ΡΠ° Π½Π° Π°Π½ΡΠΈΠ΅ΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ΅
ΠΠ΅Π½Π΅ΡΡΠΊΠΈ ΠΈ Π½Π΅Π²ΡΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΡΠΊΠΈ ΠΈΡΡΡΠ°ΠΆΡΠ²Π°ΡΠ° ΠΊΠ°Ρ ΠΌΠΈΠ³ΡΠ΅Π½Π°
ΠΠΈΠ³ΡΠ΅Π½Π°ΡΠ° ΠΈΠ°ΠΊΠΎ Π΅ ΠΏΠΎΠ·Π½Π°ΡΠ° ΡΡΡΠ΅ ΠΎΠ΄ Π°Π½ΡΠΈΡΠΊΠΈΡΠ΅ Π²ΡΠ΅ΠΌΠΈΡΠ° Π΄ΠΎ Π΄Π΅Π½Π΅Ρ ΡΠΈΠ·ΠΈΠΎΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ°ΡΠ° Π½Π° ΠΌΠΈΠ³ΡΠ΅Π½ΠΏΠ·Π½ΠΈΠΎΡ Π½Π°ΠΏΠ°Π΄ ΠΎΡΡΠ°Π½ΡΠ²Π° Π΅Π½ΠΈΠ³ΠΌΠ°. Π‘ΠΏΠΎΡΠ΅Π΄ ΡΡΠ°ΡΠΈΡΡΠΈΠΊΠ°ΡΠ° 23 ΠΌΠΈΠ»ΠΈΠΎΠ½ΠΈ ΠΠΌΠ΅ΡΠΈΠΊΠ°Π½ΡΠΈ ΡΡΡΠ°Π΄Π°Π°Ρ ΠΎΠ΄ ΠΌΠΈΠ³ΡΠ΅Π½Π°
ΠΠ΅Π²ΡΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΡΠΊΠΈ ΠΈ Π³Π΅Π½Π΅ΡΡΠΊΠΈ ΠΈΡΡΡΠ°ΠΆΡΠ²Π°ΡΠ° ΠΊΠ°Ρ ΠΌΠΈΠ³ΡΠ΅Π½Π°
Π¦Π΅Π»: ΠΠ° ΡΠ΅ ΠΎΡΠΊΡΠΈΡΠ°Ρ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»Π½ΠΈΡΠ΅ ΡΠ°ΡΡΡΠΎΡΡΡΠ²Π° ΠΊΠ°Ρ Π±ΠΎΠ»Π½ΠΈ ΡΠΎ ΠΌΠΈΠ³ΡΠ΅Π½Π° ΡΠΎ ΠΏΠΎΠΌΠΎΡ Π½Π° Π½Π΅Π²ΡΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΡΠΊΠΈΡΠ΅ ΠΈΡΡΡΠ°ΠΆΡΠ²Π°ΡΠ°, ΠΊΠ°ΠΊΠΎ ΠΈ ΡΠ°ΠΌΠΈΠ»ΠΈΡΠ°ΡΠ½Π°ΡΠ° Π΅ΠΊΡΠΏΡΠ΅ΡΠΈΡΠ° ΠΌΠΈΠ³ΡΠ΅Π½Π°ΡΠ°, Π½Π°ΡΠΈΠ½ΠΎΡ Π½Π° Π½Π°ΡΠ»Π΅Π΄ΡΠ²Π°ΡΠ΅ΡΠΎ ΠΈ Π΅Π²Π΅Π½ΡΡΠ°Π»Π½ΠΈΡΠ΅ Ρ
ΡΠΎΠΌΠΎΠ·ΠΎΠΌΡΠΊΠΈ Π°Π±Π΅ΡΠ°ΡΠΈΠΈ ΠΊΠ°Ρ ΡΠ»ΡΡΠ°ΠΈ Π½Π° ΡΠ°ΠΌΠΈΠ»ΠΈΡΠ°ΡΠ½Π° ΠΌΠΈΠ³ΡΠ΅Π½Π°, ΠΊΠΎΡΠ° ΡΠ΅ ΡΠ°Π²ΡΠ²Π° ΠΊΠ°Ρ ΠΏΠΎΠ²Π΅ΡΠ΅ ΡΠ»Π΅Π½ΠΎΠ²ΠΈ Π²ΠΎ Π΅Π΄Π½Π° ΡΠ°ΠΌΠΈΠ»ΠΈΡΠ°
Somatosensory evoked potentials in patients with thalamic pain
The aim of study was to examine how to the Somatosensory evoked potentials are affected in patients with cerebrovascular thalamic lesions and to correlate the findings with sensory abnormalities
ΠΠΌΡΠ½ΠΎΠ³Π΅Π½Π΅ΡΡΠΊΠΈ ΠΈΡΡΡΠ°ΠΆΡΠ²Π°ΡΠ° ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΡΠΎ Π΅ΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ°
ΠΠΎΡΠ»Π΅Π΄Π½ΠΈΡΠ΅ Π΄Π΅ΡΠ΅Ρ Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΠ»ΠΈΠ½ΠΈΠΊΠ°ΡΠ° Π·Π° Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ° Π²ΠΎ ΡΠΎΡΠ°Π±ΠΎΡΠΊΠ° ΡΠΎ ΠΠ½ΡΡΠΈΡΡΡΠΎΡ Π·Π° ΡΡΠ°Π½ΡΡΡΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ°, ΠΠ½ΡΡΠΈΡΡΡΠΎΡ Π·Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠΊΠ° Π±ΠΈΠΎΡ
Π΅ΠΌΠΈΡΠ° ΠΈ ΠΠ½ΡΡΠΈΡΡΡΠΎΡ Π·Π° Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ° ΠΏΡΠΈ ΠΠΊΠ°Π΄Π΅ΠΌΠΈΡΠ°ΡΠ° Π·Π° Π½Π°ΡΠΊΠ° ΡΠΏΡΠΎΠ²Π΅Π΄ΠΎΠ° ΠΈΠΌΡΠ½ΠΎΠ³Π΅Π½Π΅ΡΡΠΊΠΈ ΠΈΡΡΡΠ°ΠΆΡΠ²Π°ΡΠ° ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΡΠΎ Π΅ΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ°
Somatosensory evoked potentials in deaferentation pain
The aim of study was to examine how to the Somatosensory evoked potentials ( SEPs) are affected in patients with cerebrovascular thalamic lesions and to correlate the findings with sensory abnormalities
EEG changes in patients with Parkinson disease and epileptic attacks
ΠΠΠ-ΠΎΡ Π΅ ΠΌΠ½ΠΎΠ³Ρ Π²Π°ΠΆΠ½Π° Π΄ΠΈΡΠ°Π³Π½ΠΎΡΡΠΈΡΠΊΠ° ΠΌΠ΅ΡΠΎΠ΄Π° ΡΡΠΎ ΡΠ΅ ΠΏΡΠΈΠΌΠ΅Π½ΡΠ²Π° ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ ΡΠΎ Π΅ΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ°. ΠΠΠ ΠΏΡΠΎΠΌΠ΅Π½ΠΈΡΠ΅ ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ ΡΠΎ ΠΏΠ°ΡΠΊΠΈΠ½ΡΠΎΠ½ΠΈΠ·Π°ΠΌ ΠΈ ΡΠΎ Π΅ΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ° ΡΠ΅ ΡΠ΅ ΡΡΡΠ΅ Π½Π΅Π΄ΠΎΠ²ΠΎΠ»Π½ΠΎ ΠΏΠΎΠ·Π½Π°ΡΠΈ ΠΈ Π½Π΅ΠΎΡΠ΅ΠΊΡΠ²Π°Π½ΠΈ